ARCHIVES

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis.

October 24, 2008

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

Researchers Identify Five Genes Associated With Melanoma Risk

July 29, 2011

825,000 Pounds of Yew Bark Clleced in ’91 For 10,000 Patients

March 13, 1992

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991